TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+8.42%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
+$6.09B
(+5.7%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,445
New
84
Increased
613
Reduced
589
Closed
60
Top Buys
| 1 |
Apple
AAPL
|
+$257M |
| 2 |
UnitedHealth
UNH
|
+$226M |
| 3 |
Colgate-Palmolive
CL
|
+$217M |
| 4 |
Moody's
MCO
|
+$203M |
| 5 |
Curtiss-Wright
CW
|
+$189M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$744M |
| 2 |
Lam Research
LRCX
|
+$339M |
| 3 |
Merck
MRK
|
+$305M |
| 4 |
Vistra
VST
|
+$200M |
| 5 |
ConocoPhillips
COP
|
+$181M |
Sector Composition
| 1 | Technology | 20.68% |
| 2 | Financials | 20.15% |
| 3 | Healthcare | 11.01% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Federal Realty Investment Trust
FRT
$8.69B
| $1.59M | ﹤0.01% |
13,922
+28
| +0.2% | +$3.2K |
|
1102
Vimeo
VMEO
$1.28B
| $1.58M | ﹤0.01% |
305,986
| – | – |
|
1103
BorgWarner
BWA
$9.35B
| $1.56M | ﹤0.01% |
42,481
-524
| -1% | -$19.3K |
|
1104
Select Medical
SEM
$1.54B
| $1.56M | ﹤0.01% |
83,520
+34,522
| +70% | +$645K |
|
1105
AeroVironment
AVAV
$11.5B
| $1.55M | ﹤0.01% |
7,800
+4,700
| +152% | +$936K |
|
1106
Ryman Hospitality Properties
RHP
$6.33B
| $1.55M | ﹤0.01% |
+14,200
| New | +$1.55M |
|
1107
Heidrick & Struggles
HSII
$1.02B
| $1.55M | ﹤0.01% |
41,200
-15,200
| -27% | -$572K |
|
1108
Mohawk Industries
MHK
$8.44B
| $1.54M | ﹤0.01% |
9,717
-186
| -2% | -$29.5K |
|
1109
Organon & Co
OGN
$2.65B
| $1.54M | ﹤0.01% |
80,300
+45,100
| +128% | +$865K |
|
|
CFB
1110
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.53M | ﹤0.01% |
93,564
| – | – |
|
1111
Equity Bancshares
EQBK
$805M
| $1.53M | ﹤0.01% |
37,648
| – | – |
|
1112
FMC
FMC
$4.59B
| $1.52M | ﹤0.01% |
23,060
-303
| -1% | -$20K |
|
1113
Lyell Immunopharma
LYEL
$254M
| $1.52M | ﹤0.01% |
50,232
| – | – |
|
|
BBOT
1114
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$798M
| $1.51M | ﹤0.01% |
144,772
| – | – |
|
|
HTO
1115
H2O America Common Stock
HTO
$1.74B
| $1.51M | ﹤0.01% |
26,200
-11,300
| -30% | -$650K |
|
1116
Spyre Therapeutics
SYRE
$990M
| $1.5M | ﹤0.01% |
52,768
+17,600
| +50% | +$501K |
|
1117
Alamo Group
ALG
$2.5B
| $1.5M | ﹤0.01% |
8,300
| – | – |
|
1118
Toro Company
TTC
$7.7B
| $1.5M | ﹤0.01% |
17,326
-937,174
| -98% | -$81.2M |
|
1119
Encore Capital Group
ECPG
$999M
| $1.5M | ﹤0.01% |
31,756
| – | – |
|
1120
Origin Bancorp
OBK
$1.19B
| $1.49M | ﹤0.01% |
47,236
| – | – |
|
1121
Oric Pharmaceuticals
ORIC
$1.02B
| $1.48M | ﹤0.01% |
139,400
| – | – |
|
1122
Dime Community Bancshares
DCOM
$1.35B
| $1.48M | ﹤0.01% |
52,510
| – | – |
|
1123
Invesco
IVZ
$9.9B
| $1.47M | ﹤0.01% |
83,545
-1,247
| -1% | -$22K |
|
1124
Korn Ferry
KFY
$3.86B
| $1.47M | ﹤0.01% |
20,000
+1,400
| +8% | +$103K |
|
1125
Guidewire Software
GWRE
$21.3B
| $1.45M | ﹤0.01% |
8,158
-2,376
| -23% | -$423K |
|